{"changeSha256":"b0c1776e2057cd8bcf95d4e4ff2df2f8d873404a547bb66c15c70e72971c36b7","changedAt":"2026-11-15","changedFields":[{"after":"PeptideScanner retained ClinicalTrials.gov record NCT07531251 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was elamipretide.","before":"PeptideScanner retained ClinicalTrials.gov record NCT07531251 at 2026-08-10T18:10:04.223Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was elamipretide.","field":"Summary"},{"after":"2026-11-09","before":"2026-07-13","field":"Cited source date"},{"after":"2026-11-15","before":"2026-08-10","field":"Source observed date"},{"after":"ctg-observation-nct07531251-2026-07-13-a3abd3798f6f-r2","before":"ctg-observation-nct07531251-2026-07-13-a3abd3798f6f","field":"Cited source records"},{"after":"ctg-observation-nct07531251-2026-07-13-a3abd3798f6f-r2","before":"ctg-observation-nct07531251-2026-07-13-a3abd3798f6f","field":"Headline citations"},{"after":"ctg-observation-nct07531251-2026-07-13-a3abd3798f6f-r2","before":"ctg-observation-nct07531251-2026-07-13-a3abd3798f6f","field":"Summary citations"},{"after":"1. PeptideScanner retained ClinicalTrials.gov record NCT07531251 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was elamipretide. [sources: ctg-observation-nct07531251-2026-07-13-a3abd3798f6f-r2]\n2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct07531251-2026-07-13-a3abd3798f6f-r2]","before":"1. PeptideScanner retained ClinicalTrials.gov record NCT07531251 at 2026-08-10T18:10:04.223Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was elamipretide. [sources: ctg-observation-nct07531251-2026-07-13-a3abd3798f6f]\n2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct07531251-2026-07-13-a3abd3798f6f]","field":"Attributable context"},{"after":"b1b09dfd129e96bca737737861669ba793549d2ec86352284d46bfaf2b7b5c0d","before":"cd18ee2b24e957403e6fb8e09ac12d4bfc61572774f57546d541ffda74c3fb1f","field":"Source snapshot commitment"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07531251-elamipretide/#version-2","version":2},"id":"story:clinicaltrials-gov-nct07531251-elamipretide:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"record-updated","notice":"ClinicalTrials.gov posted a newer version of NCT07531251, with a registry update date of 2026-11-09. This version reports that observation; the earlier retained observation remains available as version 1.","peptideSlugs":["elamipretide"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07531251-elamipretide/#version-1","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"ctg-observation-nct07531251-2026-07-13-a3abd3798f6f-r2","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07531251 · retained source version 2026-11-09:8d985a85fd7cea4c1942696d014f6e48a6dd6fde4500944df40f503eef786fd1","url":"https://clinicaltrials.gov/study/NCT07531251","verifiedAt":"2026-11-15"}],"subject":{"slug":"clinicaltrials-gov-nct07531251-elamipretide","type":"story"}}
